Ashté Collins [00:00:25] So as an academic nephrologist who is busy in clinical practice, I found this to be an incredibly valuable meeting. The collaboration, the collection of all of the thought leaders and experts in this space has really been eye opening and it really gives us a lot of promise as we move forward in rare kidney disease. I’m thrilled to be a part of this. I’m thrilled to have been invited and to be practicing nephrology at a time when we can really make substantive change with our patients. So you know this all started yesterday when we heard the patient’s story, and we’re really being able to put a face on the diseases that we’re trying to take care of.

Yasir Qazi [00:01:03] And a meeting like this puts everybody in the room together, whether it’s academia, it’s private practice, a lot of experience, and kind of like analyzing where we’re at in terms of, at the end of the day, getting our patients to where they need to be, you know, be healthy, be away from dialysis as far and as remote as can be. And so a meeting like this where, you know, folks come in from all over the, you know, we had folks from Europe with, you know, United Kingdom and then from all parts of the United States coming together to, you know, look at what we have and where we can go. So it makes it really, you know, very, very important, very timely. And it’s my first time here. So I really enjoyed it.

Jessica Coleman [00:01:45] I think the unique opportunity that we have here at the RKD Summit is that we have the opportunity to not only talk about what’s currently available therapeutically for our patients, but then also explore the options to come. We’re also getting the opportunity to mix academics and community-based nephrologists, which, for my perspective as a community-based nephrologist, that collegial attitude is so just unparalleled. It’s priceless.

Tobias Huber [00:02:12] I guess we made a huge step forward by identifying the progress that we made, by further specifying our path forward and by addressing the next generation of questions to be addressed and the next generation of trials to be set up. So altogether, this summit was a huge success, and I can’t wait for our next meeting next year.